πŸ‡ΊπŸ‡Έ FDA
Patent

US 7872124

Dipeptidyl peptidase inhibitors

granted A61PA61P13/12A61P17/06

Quick answer

US patent 7872124 (Dipeptidyl peptidase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P13/12, A61P17/06, A61P19/02, A61P19/08